We're thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled "Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis", this comprehensive study compares two advanced minimally invasive techniques for removing benign ovarian cysts — Laparoendoscopic Single-Site Surgery (LESS) (using a single small incision, often hidden at the umbilicus for superior cosmetic results) and Conventional Laparoscopic Surgery (CLS) (using multiple small incisions). Analyzing data from 9 studies involving 1,368 women, the meta-analysis reveals compelling insights: LESS is associated with longer operative times (by about 9.4 minutes on average), likely due to the technical demands of working through a single port. However, patients undergoing LESS benefit from a shorter hospital stay (reduced by approximately 0.26 days). Importantly, there are no significant differences in key safety outcomes: postoperative pain scores (at 6 and 24 hours), estimated blood loss, need for opioid analgesics, drop in hemoglobin levels, or overall complication rates. These findings strengthen the evidence that LESS is a safe, effective, and viable alternative to conventional laparoscopy for women with benign ovarian cysts — offering faster recovery and excellent cosmetic advantages while maintaining comparable safety and pain profiles. This work adds valuable high-level evidence to the field of minimally invasive gynecologic surgery and reflects the Marchand Institute's ongoing commitment to advancing women's health through rigorous, volunteer-driven research. Read the full open-access paper for free today: PubMed Central (PMC) (recommended - full text & PDF): https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/ Direct PDF download: https://pmc.ncbi.nlm.nih.gov/articles/PMC12734174/pdf/jcm-14-08739.pdf Published in Journal of Clinical Medicine (December 10, 2025) – DOI: 10.3390/jcm14248739 We invite clinicians, researchers, and patients interested in the latest advancements in minimally invasive surgery to explore this important contribution. A huge thank you to our incredible team of researchers, students, and collaborators who made this possible — all volunteer efforts dedicated to improving outcomes for women everywhere! Visit us at marchandinstitute.org to learn more about our ongoing research, educational programs, and mission to push the boundaries of minimally invasive techniques.

Newest Paper on Laparoscopic Single Site Ovarian Cystectomy Online Now!

FOR IMMEDIATE RELEASE MESA, Ariz. — January 1, 2026 We’re thrilled to announce the publication of a groundbreaking systematic review and meta-analysis led by Dr. Greg Marchand and the dedicated research team at the Marchand Institute for Minimally Invasive Surgery! Titled “Laparoendoscopic Single-Site Surgery Versus Conventional Laparoscopic Surgery in Ovarian Cystectomy: A Meta-Analysis”, this comprehensive…

Laparoscopy, Laproscopy, Minimally Invasive Surgery, OBGYN

Marchand Institute, the First Major Research Group to Include Statement of Diversity and Inclusion on All Publications – Now Recommends for All Research Institutions

FOR IMMEDIATE RELEASE MESA, Ariz. — March 15, 2022 Since 2019, The Marchand Institute has displayed a paragraph on all publications proudly stating their dedication to diversity, inclusion, and the maintenance of a workplace free of racism and sexism. This declaration, in accordance with our not-for-profit mission for women’s health, is very much a part…

Minimally Invasive Surgery, OBGYN